Alzheimer’s: Tanycytes & Tau Protein Build-Up – New Research

The accumulation of tau protein is a hallmark of Alzheimer’s disease and a fresh study is shedding light on a previously overlooked part of the brain that may play a critical role in clearing this toxic protein. Researchers have identified specialized brain cells, called tanycytes, that appear to be involved in transporting tau away from the brain, and dysfunction in these cells could contribute to the progression of Alzheimer’s. The findings, published March 5 in the journal Cell Press Blue, combine experiments in animal models, cell studies, and analyses of tissue from human patients, offering a potentially new avenue for therapeutic intervention.

Tanycytes: Gatekeepers Between Brain and Body

Tanycytes are not neurons – they are non-neuronal cells primarily located in the third ventricle of the brain. For some time, scientists have known that tanycytes act as a crucial interface between the brain and the rest of the body, helping to regulate communication via metabolic signals. They move substances between the bloodstream and the cerebrospinal fluid (CSF), the fluid that surrounds the brain and spinal cord. This CSF network is vital for maintaining the brain’s internal balance, a process known as homeostasis. Neuroscience News provides a helpful overview of these cells and their known functions.

How Tanycytes Clear Toxic Tau

The recent study investigated how tanycytes contribute to the removal of harmful molecules, specifically tau, from the brain. Researchers discovered that these cells actively transport toxic substances, including tau, from the CSF into the bloodstream, where they can be eliminated from the body. When this transport system is impaired, tau begins to accumulate, potentially leading to the formation of tangles that disrupt brain function and are characteristic of Alzheimer’s disease. “Surprisingly, we were able to show in rodent and cellular models not only that tanycytes were indeed involved in clearing tau but also that tanycytes in the brains of human Alzheimer’s patients were fragmented and had changes in gene expression related to this shuttle function,” explained corresponding author Vincent Prevot of INSERM in France.

Alzheimer’s Progression and Tanycyte Dysfunction

The research team’s analysis of brain tissue from Alzheimer’s patients revealed significant changes in tanycytes. They observed that these cells were fragmented and exhibited alterations in gene expression related to their transport function. This suggests that tanycyte dysfunction is not merely a consequence of Alzheimer’s disease, but may actively contribute to its progression. Genetic Engineering and Biotechnology News details how degenerating tanycytes disrupt tau removal, shaping the course of the disease.

Implications for Treatment and Future Research

These findings suggest that maintaining the health of tanycytes could be a promising strategy for slowing down neurodegeneration in Alzheimer’s disease. By enhancing the brain’s natural clearance mechanisms, it may be possible to reduce tau buildup and mitigate the disease’s effects. However, researchers caution that developing treatments targeting tanycytes will be challenging. One significant hurdle is the limited availability of animal models that accurately replicate the complexities of Alzheimer’s disease in humans. Further research, including larger patient studies and long-term investigations, is needed to fully understand the relationship between tanycyte dysfunction and tau accumulation.

Challenges in Modeling Alzheimer’s Disease

Creating accurate animal models for Alzheimer’s disease has proven difficult. Existing models often only mimic certain aspects of the disease, making it challenging to translate findings from animal studies to human patients. This limitation underscores the need for more sophisticated models and careful interpretation of research results. The National Institutes of Health (https://www.nih.gov/) funds extensive research into Alzheimer’s disease and the development of improved animal models.

What Comes Next: Refining Understanding and Exploring Therapies

The researchers emphasize that their operate represents a first step in understanding the role of tanycytes in Alzheimer’s disease. Future studies will focus on identifying the specific mechanisms that cause tanycyte dysfunction and exploring potential therapeutic interventions to protect and restore their function. This includes investigating whether pharmacological agents or other interventions can enhance tanycyte activity and improve tau clearance. The European Research Council (https://erc.europa.eu/) provided funding for this research, highlighting the international effort to combat Alzheimer’s disease. Further investigation will also be needed to determine if tanycyte health can be used as a biomarker to track disease progression and assess the effectiveness of new treatments.

The discovery of tanycytes’ role in tau clearance offers a fresh perspective on Alzheimer’s disease, moving beyond traditional focuses on neurons and amyloid plaques. Even as much work remains to be done, this research provides a valuable new target for therapeutic development and a deeper understanding of the complex processes underlying this devastating disease. Individuals concerned about Alzheimer’s disease or cognitive decline should consult with a qualified healthcare professional for accurate diagnosis and personalized care.